1. Home
  2. FOFO vs MRKR Comparison

FOFO vs MRKR Comparison

Compare FOFO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

N/A

Current Price

$2.01

Market Cap

19.2M

Sector

N/A

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$0.97

Market Cap

19.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOFO
MRKR
Founded
2017
1999
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
19.5M
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
FOFO
MRKR
Price
$2.01
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
★ 194.4K
162.3K
Earning Date
12-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
$11.09
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.70
$0.84
52 Week High
$14.93
$2.46

Technical Indicators

Market Signals
Indicator
FOFO
MRKR
Relative Strength Index (RSI) 45.90 43.06
Support Level $1.76 $0.88
Resistance Level $2.68 $1.34
Average True Range (ATR) 0.19 0.10
MACD -0.00 0.01
Stochastic Oscillator 28.57 26.97

Price Performance

Historical Comparison
FOFO
MRKR

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: